🟢 MBX Biosciences is trading 4.3% up today amid positive biotech-sector sentiment

MBX Biosciences is trading 4.26% up now at $55.78, with positive biotech sentiment the likeliest context for the move.

• The share move is on October 21, 2026; no clear company-specific announcement explaining it surfaced in the search.
• The latest listed company release was an October 13 investor-conference notice.
• Merck’s announced acquisition of Silence Therapeutics is sector context, not a direct MBX Biosciences catalyst.